Creating demand for prescription drugs: A content analysis of television direct-to-consumer advertising

被引:167
作者
Frosch, Dominick L.
Krueger, Patrick M.
Hornik, Robert C.
Cronholm, Peter F.
Barg, Frances K.
机构
[1] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA
[2] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA
[3] Univ Texas, Hlth Sci Ctr, Sch Publ Hlth, Houston, TX 77025 USA
[4] Univ Texas, Populat Res Ctr, Austin, TX 78712 USA
[5] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[6] Univ Penn, Annenberg Sch Commun, Philadelphia, PA 19104 USA
[7] Univ Penn, Dept Family Med & Community Hlth, Philadelphia, PA 19104 USA
关键词
pharmaceutical marketing; consumers; content analysis; qualitative research; advertising;
D O I
10.1370/afm.611
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
PURPOSE American television viewers see as many as 16 hours of prescription drug advertisements (ads) each year, yet no research has examined how television ads attempt to influence consumers. This information is important, because ads may not meet their educational potential, possibly prompting consumers to request prescriptions that are clinically inappropriate or more expensive than equally effective alternatives. METHODS We coded ads shown during evening news and prime time hours for factual claims they make about the target condition, how they attempt to appeal to consumers, and how they portray the medication and lifestyle behaviors in the lives of ad characters. RESULTS Most ads (82%) made some factual claims and made rational arguments (86%) for product use, but few described condition causes (26%), risk factors (26%), or prevalence (25%). Emotional appeals were almost universal (95%). No ads mentioned lifestyle change as an alternative to products, though some (19%) portrayed it as an adjunct to medication. Some ads (18%) portrayed lifestyle changes as insufficient for controlling a condition. The ads often framed medication use in terms of losing (58%) and regaining control (85%) over some aspect of life and as engendering social approval (78%). Products were frequently (58%) portrayed as,a medical breakthrough. CONCLUSIONS Despite claims that ads serve an educational purpose, they provide limited information about the causes of a disease or who may be at risk; they show characters that have lost control over their social, emotional, or physical lives without the medication; and they minimize the value of health promotion through lifestyle changes. The ads have limited educational value and may oversell the benefits of drugs in ways that might conflict with promoting population health.
引用
收藏
页码:6 / 13
页数:8
相关论文
共 50 条
[31]   Evaluation of Risk Versus Benefit Information in Direct-To-Consumer (DTC) Prescription Drug Television Advertisements [J].
Fahim, Germin ;
Toscani, Michael ;
Barone, Joseph A. ;
Wang, Chris ;
Gandhi, Shivani .
THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2018, 52 (01) :114-117
[32]   Evaluation of Risk Versus Benefit Information in Direct-To-Consumer (DTC) Prescription Drug Television Advertisements [J].
Germin Fahim ;
Michael Toscani ;
Joseph A. Barone ;
Chris Wang ;
Shivani Gandhi .
Therapeutic Innovation & Regulatory Science, 2018, 52 :114-117
[33]   Consumer responses to direct to consumer prescription drug advertising [J].
Chen, Hai D. B. ;
Carroll, Norman V. .
INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND HEALTHCARE MARKETING, 2007, 1 (04) :276-289
[34]   The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements [J].
Sullivan, Helen W. ;
O'Donoghue, Amie C. ;
Lynch, Molly ;
Johnson, Mihaela ;
Davis, Christine ;
Rupert, Douglas J. .
MEDICAL DECISION MAKING, 2019, 39 (08) :975-985
[35]   Communicating therapeutic indication information in direct-to-consumer television ads for prescription cancer drugs: Exploring the effect of dual-modality presentations [J].
Boudewyns, Vanessa ;
Paquin, Ryan S. ;
Sullivan, Helen W. ;
O'Donoghue, Amie C. .
PATIENT EDUCATION AND COUNSELING, 2025, 132
[36]   Racial and ethnic disparities in response to direct-to-consumer advertising [J].
Lee, Doohee ;
Begley, Charles E. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (14) :1185-1190
[37]   Gender bias in antidepressant direct-to-consumer pharmaceutical advertising [J].
Asadi, Leila K. ;
Shah, Asim A. .
COMPREHENSIVE PSYCHIATRY, 2023, 123
[38]   Content Analysis of Television Advertising for Drugs That Switch From Prescription to Over-the-Counter: Balancing Information and Appeals [J].
Faerber, Adrienne E. ;
Kreling, David H. .
DRUG INFORMATION JOURNAL, 2012, 46 (02) :226-234
[39]   'Ask your doctor about...': Direct-to-consumer prescription drug advertising and the HIV/AIDS medical marketplace [J].
Fuqua, JV .
CULTURAL STUDIES, 2002, 16 (05) :650-672
[40]   Relationship between direct-to-consumer advertising and physician diagnosing and prescribing [J].
Zachry, WM ;
Shepherd, MD ;
Hinich, MJ ;
Wilson, JP ;
Brown, CM ;
Lawson, KA .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (01) :42-49